Outset Medical (OM) Gains from Investment Securities (2018 - 2026)

Outset Medical (OM) reported Gains from Investment Securities of $85000.0 for Q1 2026, down 98.05% quarter-over-quarter from $4.4 million in Q2 2025.

Outset Medical (OM) Gains from Investment Securities (2018 - 2026) Analysis & Trends

Outset Medical (OM) has 6 years of Gains from Investment Securities data on file, last reported at $85000.0 in Q1 2026.

Gains from Investment Securities for Q1 2026 came in at $85000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $4.5 million (changed N/A YoY), and the FY2025 annual result was $81000.0, down 11.96% from the prior year.
Gains from Investment Securities fell to $85000.0 in Q1 2026 per OM's latest filing, from $4.4 million in the prior quarter.
Over five years, Gains from Investment Securities peaked at $4.4 million in Q2 2025 and troughed at -$528000.0 in Q4 2023.
A 3-year average of $1.3 million and a median of $85000.0 in 2026 frame the typical range for Gains from Investment Securities.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn
10	Outset Medical	81,759.85	-286.56 Mn	12.10 Mn

Download Data